Skip to main content

Articles

Brintellix (Vortioxetine) Receives FDA Approval for the Treatment of Major Depressive Disorder

Injectafer (Ferric Carboxymaltose Injection) Receives FDA Approval for the Treatment of Iron-Deficiency Anemia

Practice Management

Insurance Companies’ Perspectives on the Orphan Drug Pipeline

Stakeholder Perspective

Breakthrough Therapy, or Breakthrough Pricing?

Practice Management

“Project IMPACT: Diabetes” Care Model Improves Health Outcomes in Underserved Populations in 25 Communities with a High Incidence of Diabetes

Practice Management

Cost and Drug Utilization Patterns Associated with the Management of Rosacea

Practice Management, Pulmonary

Rehospitalization Is Driving Costs in Pulmonary Arterial Hypertension

Original Research

Pharmacy Staff Opinions Regarding Diabetic Retinopathy Screenings in the Community Setting: Findings from a Brief Survey

Stakeholder Perspective

Screening for Diabetic Retinopathy in the Community Setting: Exploring the Options

Practice Management

Modeling the Frequency and Costs Associated with Postsurgical Gastrointestinal Adverse Events for Tapentadol IR versus Oxycodone IR

Stakeholder Perspective

Can Substituting Generic Drugs with Brand-Name Agents for Acute Pain Postsurgery Help to Deliver Cost-Effective, Quality Care?

Practicing Population Health

The Affordable Care Act Conundrum: Facing Reality in America’s Giant Social Experiment

Page 161 of 244
Results 1601 - 1610 of 2434